Acenocoumarol
Indications: - Other specified diseases of arteries or arterioles - Venous thromboembolism - Cerebral ischaemic stroke due to embolic occlusion - Atrial fibrillation Source: EML workbook import
MOQ: 1
Price on request
Medicines affecting coagulation catalogue banner
Medicines affecting coagulation
Imported from EML workbook.
All Medicines affecting coagulation (Showing 12 out of 15)
Apixaban
Indications: - Other specified atrial fibrillation - Venous thromboembolism Source: EML workbook import
MOQ: 1
Price on request
Dabigatran
Formulations: - Oral > Solid: 110 mg; 150 mg Indications: - Other specified atrial fibrillation - Venous thromboembolism Source: EML workbook import
MOQ: 1
Price on request
Dalteparin
Indications: - Venous thromboembolism - Acute ischaemic heart disease Source: EML workbook import
MOQ: 1
Price on request
Desmopressin
Formulations: - Parenteral > General injections > IV: 4 µg per mL in 1 mL ampoule (acetate) Local > Nasal > Spray: 150 µg per actuation (acetate) Indications: - Haemophilia A - Von Willebrand disease Source: EML workbook import
MOQ: 1
Price on request
Edoxaban
Indications: - Other specified atrial fibrillation - Venous thromboembolism Source: EML workbook import
MOQ: 1
Price on request
Emicizumab
Formulations: - Parenteral > General injections > SC: 12 mg per 0.4 mL in vial; 30 mg per mL in mL vial; 60 mg per 0.4 mL in vial; 105 mg per 0.7 mL in vial; 150 mg per mL in vial; 300 mg per 2 mL in vial Indications: - Haemophilia A Source: EML workbook import
MOQ: 1
Price on request
Enoxaparin
Formulations: - Parenteral > General injections > SC: 20 mg per 0.2 mL in prefilled syringe; 40 mg per 0.4 mL in prefilled syringe; 60 mg per 0.6 mL in prefilled syringe; 80 mg per 0.8 mL in prefilled syringe; 100 mg per 1 mL in prefilled syringe; 120 mg per 0.8 mL in prefilled syringe; 150 mg per 1 mL in prefilled syringe; 150 mg per 1 mL in ampoule; 20 mg per 0.2 mL in ampoule; 40 mg per 0.4 mL in ampoule; 60 mg per 0.6 mL in ampoule; 80 mg per 0.8 mL in ampoule; 100 mg per 1 mL in ampoule; 120 mg per 0.8 mL in ampoule Indications: - Venous thromboembolism - Acute ischaemic heart disease Source: EML workbook import
MOQ: 1
Price on request
Heparin Sodium
Formulations: - Parenteral > General injections > IV: 1000 IU per mL in 1 mL ampoule or vial; 20000 IU per mL in 1 mL ampoule or vial; 5000 IU per mL in 1 mL ampoule or vial Indications: - Acute ischaemic heart disease - Unstable angina - Venous thromboembolism Source: EML workbook import
MOQ: 1
Price on request
Nadroparin
Indications: - Venous thromboembolism - Acute ischaemic heart disease Source: EML workbook import
MOQ: 1
Price on request
Phytomenadione
Formulations: - Parenteral > General injections > IV: 10 mg per mL in ampoule; 1 mg per mL in ampoule; 2 mg per 0.2 mL in ampoule mixed micelle solution; 10 mg per mL in ampoule mixed micelle solution; 1 mg per 0.5 mL in ampoule Oral > Solid > tablet: 5 mg tablet Indications: - Haemorrhagic disorder due to circulating anticoagulants or coagulation factors inhibitors - Haemorrhagic or haematological disorders of fetus or newborn Source: EML workbook import
MOQ: 1
Price on request
Protamine Sulfate
Formulations: - Parenteral > General injections > IV: 10 mg per mL in 5 mL ampoule or vial Indications: - Haemorrhagic disorder due to circulating anticoagulants or coagulation factors inhibitors Source: EML workbook import
MOQ: 1
Price on request
Sign Up to Our Newsletter→
Ready to amplify your rewards? Drop your email and we'll be in touch soon.